Gene therapy for blindness heading for approval – Cosmos (blog)
Cosmos (blog) |
Gene therapy for blindness heading for approval
Cosmos (blog) The US Food and Drug Administration looks set to approve a gene therapy for the treatment of a rare form of blindness, following clinical trials and the recommendation of a panel of independent advisors. The therapy, marketed as Luxturna by developers … Spark Therapeutics's success is lifting all gene therapy stocks even though risks remain New gene therapy gives hope to people born with inherited eye disorder FDA advisory committee vote 16-0 for first even gene therapy for rare blindness |
